Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan
Aging Cell · 2026
DOI: 10.1111/acel.70736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Lei Justan Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Masonic Institute on the Biology of Aging and Metabolism, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Cellular Senescence, Flavonoids, Senotherapeutics, Drug Discovery. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIA NIH HHS, Glenn Foundation for Medical Research.
Abstract (Originalsprache)
Senescent cells are a key driver of aging and contribute to many age‐related diseases. Senolytics, agents that selectively eliminate senescent cells, offer a promising therapeutic strategy to treat age‐related diseases but face significant barriers to clinical translation. Fisetin, a natural flavonoid senolytic, has progressed to clinical trials but is limited by suboptimal efficacy and poor bioavailability. To address these challenges, we developed two novel fisetin‐derived flavonoid senolytics, SR29384 and SR31133, using an integrative phenotypic drug discovery approach. These compounds exhibit enhanced senolytic activity, targeting a broad range of senescent cell types, reducing tissue senescence, and improving healthspan‐associated parameters in mouse models of aging. Mechanistic investigations combining transcriptomics, machine learning, network pharmacology, and molecular docking revealed that these novel senolytics may target key molecular pathways, including PARP1, CDK2, and possibly BCL‐xL to selectively induce apoptosis in senescent cells. These findings provide novel senolytics with high translational potential for clinical applications in promoting healthy aging and treating age‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Masonic Institute on the Biology of Aging and Metabolism, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA.
- Innovations in Drug Discovery Program, Department of Pharmaceutical & Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia, USA.
- The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, Florida, USA.
- Department of Medicine and Aging Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.
ORCID-Profile: Lei Justan Zhang, Rahagir Salekeen, Carolina Soto-Palma, Osama Elsallabi, Allancer Nunes, Wandi Xu, Sara J McGowan, Laura J Niedernhofer, Paul D Robbins
Förderung
- NIH HHS
- NIA NIH HHS
- Glenn Foundation for Medical Research
- National Institutes of Health
Zitieren
APA
Zhang, L. J., Salekeen, R., Soto-Palma, C., Wu, Q., He, Y., Elsallabi, O., Bdiri, B., Hughes, B., Nunes, A., Xu, W., Zhang, B., Mohamed, A., McGowan, S. J., Angelini, L., O'Kelly, R., Kamenecka, T. M., Niedernhofer, L. J., & Robbins, P. D. (2026). Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan. Aging Cell. https://doi.org/10.1111/acel.70736
Vancouver
Zhang LJ, Salekeen R, Soto-Palma C, Wu Q, He Y, Elsallabi O, et al. Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan. Aging Cell. 2026. doi:10.1111/acel.70736
BibTeX
@article{Zhang2026,
author = {Zhang, Lei Justan and Salekeen, Rahagir and Soto-Palma, Carolina and Wu, Qiuming and He, Yuanjun and Elsallabi, Osama and Bdiri, Bilel and Hughes, Brian and Nunes, Allancer and Xu, Wandi and Zhang, Borui and Mohamed, Abdalla and McGowan, Sara J and Angelini, Luise and O'Kelly, Ryan and Kamenecka, Theodore M and Niedernhofer, Laura J and Robbins, Paul D},
title = {Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70736}
}
EUVIMED